Healthcare and Research Infrastructure
Claim Your Profile to Add Information
Description
North Carolina has solidified its status as a premier global hub for the life sciences ecosystem, consistently ranking among the top clusters in the US for biotechnology and pharmaceutical manufacturing.
At the heart of this growth is Research Triangle Park (RTP), a world-renowned epicenter that fosters synergy between industry titans and academic research powerhouses like Duke, UNC-Chapel Hill and NC State.
The state is best known for its robust biomanufacturing infrastructure, attracting multi-billion dollar investments from leaders such as Pfizer, Eli Lilly and Fujifilm Diosynth.
Beyond traditional pharma, North Carolina is a pioneer in healthcare innovation, driving advancements in cell and gene therapy, regenerative medicine and clinical research through a dense network of CROs.
The medical device sector also thrives here, supported by specialized hubs like the Pearl Medical Innovation District in Charlotte and the Innovation Quarter in Winston-Salem.
Bolstered by a highly skilled workforce development pipeline and a favorable business climate, the state offers unparalleled scalability for biotech startups and established enterprises alike.
From drug discovery to large-scale commercial production, North Carolina provides the specialized infrastructure required for the future of precision medicine. This integrated environment ensures that life-saving therapies move rapidly from the laboratory to the global marketplace.
Featured Editorial
Regions
Government and Public Research Funding
Claim Your Profile to Add Information
Investment and Financing
Claim Your Profile to Add Information
Industry Presence
Claim Your Profile to Add Information
Big Medtech Presence
Claim Your Profile to Add Information
Active Clinical Studies
Claim Your Profile to Add Information
